We have previously reported that syndecan-1 (CD138) up-regulates miR-331-3p expression by directly targeting neuropilin 2 (NRP2) and nucleus accumbens-associated protein 1 (NACC1) to mediate the EMT in prostate cancer cells [13]. Here, NRP2 is linked to Familial prostate cancer.